Showing results (161-170 of 562) with videos related to
Sort By:
Pageof 57
Journal of Gastrointestinal Oncology|July 20, 2012
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisalUmashankar K Ballehaninna, Ronald S ChamberlainExpert Reviews in Molecular Medicine|June 27, 2009
Emerging strategies for cell and gene therapy of the muscular dystrophiesLindsey A Muir, Jeffrey S ChamberlainDigestive Surgery|July 11, 2009
A comprehensive review of evidence-based strategies to prevent and treat postoperative ileusSara K Story, Ronald S ChamberlainHuman Molecular Genetics|June 26, 2019
AAV-based gene therapies for the muscular dystrophiesJulie M Crudele, Jeffrey S ChamberlainCurrent Biology : CB|November 21, 2000
Muscular dystrophy: the worm turns to genetic diseaseJ S Chamberlain, G M BenianMicroscopy Research and Technique|February 19, 2000
Developments in gene therapy for muscular dystrophyD Hartigan-O'Connor, J S ChamberlainMolecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2017
Progress toward Gene Therapy for Duchenne Muscular DystrophyJoel R Chamberlain, Jeffrey S ChamberlainMolecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Recombinant adeno-associated virus transduction and integrationBrian R Schultz, Jeffrey S ChamberlainThe American Surgeon|December 17, 2014
Surgeons and their tools: a history of surgical instruments and their innovators--Part II: The surgeon's wand-evolution from knife to scalpel to electrocauteryAbraham El-Sedfy, Ronald S ChamberlainIndian Journal of Surgical Oncology|June 14, 2012
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive ReviewUmashankar K Ballehaninna, Ronald S ChamberlainPageof 57